111 related articles for article (PubMed ID: 14552811)
21. GM2 ganglioside in fetal Tay-Sachs disease brain cultures: a model system for the disease.
Hoffman LM; Amsterdam D; Schneck L
Brain Res; 1976 Jul; 111(1):109-17. PubMed ID: 953690
[TBL] [Abstract][Full Text] [Related]
22. GM2 ganglioside and pyramidal neuron dendritogenesis.
Walkley SU; Siegel DA; Dobrenis K
Neurochem Res; 1995 Nov; 20(11):1287-99. PubMed ID: 8786814
[TBL] [Abstract][Full Text] [Related]
23. [Isolation and characteristics of hexosaminidase A and activator protein from human kidney].
Aronovich EL; Akhunov VS; Krasnopol'skaia KD
Biokhimiia; 1990 Jan; 55(1):43-51. PubMed ID: 2140519
[TBL] [Abstract][Full Text] [Related]
24. Accumulation of ganglioside Gm2 in cerebrospinal fluid of a patient with the variant AB of infantile Gm2 gangliosidosis.
Pullarkat RK; Reha H; Beratis NG
Pediatrics; 1981 Jul; 68(1):106-8. PubMed ID: 7243492
[TBL] [Abstract][Full Text] [Related]
25. Glycosphingolipids in insects. The amphoteric moiety, N-acetylglucosamine-linked phosphoethanolamine, distinguishes a group of ceramide oligosaccharides from the pupae of Calliphora vicina (Insecta: Diptera).
Helling F; Dennis RD; Weske B; Nores G; Peter-Katalinic J; Dabrowski U; Egge H; Wiegandt H
Eur J Biochem; 1991 Sep; 200(2):409-21. PubMed ID: 1889407
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system.
Schwarzmann G; Wendeler M; Sandhoff K
Glycobiology; 2005 Dec; 15(12):1302-11. PubMed ID: 16079415
[TBL] [Abstract][Full Text] [Related]
27. A novel glycosphingolipid hydrolyzing enzyme, glycosphingolipid ceramide deacylase, which cleaves the linkage between the fatty acid and sphingosine base in glycosphingolipids.
Hirabayashi Y; Kimura M; Matsumoto M; Yamamoto K; Kadowaki S; Tochikura T
J Biochem; 1988 Jan; 103(1):1-4. PubMed ID: 3360750
[TBL] [Abstract][Full Text] [Related]
28. Gangliosides of liver tumors induced by N-2-fluorenylacetamide. I. Ganglioside alterations in liver tumorigenesis and normal development.
Merritt WD; Richardson CL; Keenan TW; Morré DJ
J Natl Cancer Inst; 1978 Jun; 60(6):1313-27. PubMed ID: 206706
[TBL] [Abstract][Full Text] [Related]
29. Specific expression of unusual GM2 ganglioside with Hanganutziu-Deicher antigen activity on human colon cancers.
Hirabayashi Y; Kasakura H; Matsumoto M; Higashi H; Kato S; Kasai N; Naiki M
Jpn J Cancer Res; 1987 Mar; 78(3):251-60. PubMed ID: 3106281
[TBL] [Abstract][Full Text] [Related]
30. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.
O'Brien JS; Norden GW; Miller AL; Frost RG; Kelly TE
Clin Genet; 1977 Mar; 11(3):171-83. PubMed ID: 13950
[TBL] [Abstract][Full Text] [Related]
31. Sialidase-mediated depletion of GM2 ganglioside in Tay-Sachs neuroglia cells.
Igdoura SA; Mertineit C; Trasler JM; Gravel RA
Hum Mol Genet; 1999 Jun; 8(6):1111-6. PubMed ID: 10332044
[TBL] [Abstract][Full Text] [Related]
32. Ganglioside GM2: a potential biomarker for cholangiocarcinoma.
Talabnin K; Talabnin C; Kumagai T; Sutatum N; Khiaowichit J; Dechsukhum C; Ishihara M; Azadi P; Sripa B
J Int Med Res; 2020 Jul; 48(7):300060520903216. PubMed ID: 32692591
[TBL] [Abstract][Full Text] [Related]
33. Isolation and characterization of a novel monosialosylpentahexosyl ceramide from Tay-Sachs brain.
Itoh T; Li YT; Li SC; Yu RK
J Biol Chem; 1981 Jan; 256(1):165-9. PubMed ID: 7451432
[TBL] [Abstract][Full Text] [Related]
34. Preparation of radiolabeled GM2 and GA2 gangliosides.
Novak A; Lowden JA; Gravel YL; Wolfe LS
J Lipid Res; 1979 Jul; 20(5):678-81. PubMed ID: 490046
[TBL] [Abstract][Full Text] [Related]
35. Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine.
Kitamura K; Livingston PO; Fortunato SR; Stockert E; Helling F; Ritter G; Oettgen HF; Old LJ
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2805-9. PubMed ID: 7708728
[TBL] [Abstract][Full Text] [Related]
36. GM2-1 pancreatic islet ganglioside: identification and characterization of a novel islet-specific molecule.
Dotta F; Previti M; Lenti L; Dionisi S; Casetta B; D'Erme M; Eisenbarth GS; Di Mario U
Diabetologia; 1995 Sep; 38(9):1117-21. PubMed ID: 8591828
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.
Tsuji D; Higashine Y; Matsuoka K; Sakuraba H; Itoh K
Clin Chim Acta; 2007 Mar; 378(1-2):38-41. PubMed ID: 17196574
[TBL] [Abstract][Full Text] [Related]
38. Design and efficient synthesis of novel GM2 analogues with respect to the elucidation of the function of GM2 activator.
Komori T; Ando T; Imamura A; Li YT; Ishida H; Kiso M
Glycoconj J; 2008 Oct; 25(7):647-61. PubMed ID: 18368480
[TBL] [Abstract][Full Text] [Related]
39. Murine Sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease.
Seyrantepe V; Demir SA; Timur ZK; Von Gerichten J; Marsching C; Erdemli E; Oztas E; Takahashi K; Yamaguchi K; Ates N; Dönmez Demir B; Dalkara T; Erich K; Hopf C; Sandhoff R; Miyagi T
Exp Neurol; 2018 Jan; 299(Pt A):26-41. PubMed ID: 28974375
[TBL] [Abstract][Full Text] [Related]
40. Quantitative analysis of the molecular species of monosialogangliosides by continuous-flow fast-atom bombardment mass spectrometry.
Chen S; Pieraccini G; Moneti G
Rapid Commun Mass Spectrom; 1991 Dec; 5(12):618-21. PubMed ID: 1811797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
